Xiaojian Zhu

9PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Nonlinear optics and spectroscopy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 07, 2025
Immune-Related Adverse Events in a Patient With Burkitt's Lymphoma During PD-1 Immune Consolidation Therapy: A Case Report.

Qi Zhang, Fankai Meng, Yang Cao

|Oct 24, 2025
Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL.

Xiaoying Zhang, Jue Wang, Na Wang

|Jul 24, 2024
Correction: Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control.

Haolong Lin, Jiali Cheng, Li Zhu

|Jun 18, 2024
Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control.

Haolong Lin, Jiali Cheng, Li Zhu

|Jun 17, 2024
Updates of primary central nervous system lymphoma.

Jiaying Wu, Delian Zhou, Xiaojian Zhu

|Sep 27, 2022
CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations.

Ling Tang, Hongming Huang, Yutong Tang

Pageof 2

Frequent Collaborators

3 joint publications

Yi Xiao

2 joint publications

Jiaying Wu

2 joint publications

Haolong Lin

2 joint publications

Yuhao Zeng